T. Rowe Price leans into equity weakness

T.Rowe Price equities fixed income asset allocation

17 April 2020
| By Laura Dew |
image
image
expand image

T. Rowe Price is “leaning into weakness” created by the COVID-19 pandemic by adding exposure to high yield bonds and equities.

In a monthly update on its global asset allocation, managers Richard Coghlan, Randal Jenneke, Thomas Poullaouec and Wenting Shen said allocations to equities had moved up to overweight while fixed income was an underweight, despite the high yield additions.

“Amid the coronavirus-related sell-off in risk assets, we have incrementally added to equities over the month as the broad-based, indiscriminate selling has created opportunities to buy into quality companies at discounted levels,” they said.

Within equities, it was overweight on European, Japan and emerging market equities, neutral on Australia and global equities and underweight the US. The reason for the underweight to the US was it was concerned about elevated corporate leverage and government debt levels as well as the higher economic impact of social distancing.

In the fixed income portion, it said: “We added to high yield bonds as spreads have reached attractive entry points that historically have led to the sector delivering equity-like returns, with lower volatility over our 12 to 18 month investment horizon”.

While it had added to high yield bonds, it had reduced exposure to higher-quality sovereign bonds that it felt had reached extreme valuations.

The firm was now overweight Australian bonds, global high yield, emerging market dollar sovereigns and emerging market local currency and underweight global bonds.

Performance of T. Rowe Price Global Equity fund v MSCI ACWI index over three months to 31 March, 2020.

Read more about:

AUTHOR

Recommended for you

sub-bgsidebar subscription

Never miss the latest news and developments in wealth management industry

MARKET INSIGHTS

Completely agree Peter. The definition of 'significant change is circumstances relevant to the scope of the advice' is s...

1 month 3 weeks ago

This verdict highlights something deeply wrong and rotten at the heart of the FSCP. We are witnessing a heavy-handed, op...

2 months ago

Interesting. Would be good to know the details of the StrategyOne deal....

2 months ago

SuperRatings has shared the median estimated return for balanced superannuation funds for the calendar year 2024, finding the year achieved “strong and consistent positiv...

2 weeks 2 days ago

Original bidder Bain Capital, which saw its first offer rejected in December, has returned with a revised bid for Insignia Financial....

1 week 2 days ago

The FAAA has secured CSLR-related documents under the FOI process, after an extended four-month wait, which show little analysis was done on how the scheme’s cost would a...

1 week ago

TOP PERFORMING FUNDS